<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2008-12-2-7-15</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1024</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПЕРЕДОВАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LEADING ARTICLE</subject></subj-group></article-categories><title-group><article-title>ПРОДЛЁННЫЙ ЕЖЕДНЕВНЫЙ ДИАЛИЗ</article-title><trans-title-group xml:lang="en"><trans-title>EXTENDED DAILY DIALYSIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Килстейн</surname><given-names>Я. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Kielstein</surname><given-names>J. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>отделение нефрологии кафедры внутренних болезней</p></bio><bio xml:lang="en"><p>Division of Nephrology, Department of Internal Medicine,</p><p>Carl-Neuberg-Straβe 1, 30625 Hannover, Germany,</p><p>Phone: (49) 511– 532 6319, Fax: (49) 511– 55 23 66</p></bio><email xlink:type="simple">kielstein@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Флизер</surname><given-names>Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Fliser</surname><given-names>D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>отделение заболеваний почек и гипертензии кафедры внутренних болезней</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ганноверская медицинская школа, Ганновер</institution><country>Германия</country></aff><aff xml:lang="en"><institution>Medical School Hannover, Hannover</institution><country>Germany</country></aff></aff-alternatives><aff xml:lang="ru" id="aff-2"><institution>Университетский центр земли Саар, Хомбург/Саар</institution><country>Germany</country></aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>10</day><month>02</month><year>2008</year></pub-date><volume>12</volume><issue>2</issue><fpage>7</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Килстейн Я.Т., Флизер Д., 2008</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="ru">Килстейн Я.Т., Флизер Д.</copyright-holder><copyright-holder xml:lang="en">Kielstein J.T., Fliser D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1024">https://journal.nephrolog.ru/jour/article/view/1024</self-uri><abstract><p>Продленный ежедневный диализ (ПЕД) становится все более популярным методом экстракорпоральной заместительной почечной терапии для пациентов с острым повреждением почек в практике отделения интенсивной терапии (ОИТ). Продолжительное диализное время (обычно 8–18 часов), низкий поток диализата и крови являются ключевыми элементами ПЕД – как метода заместительной почечной терапии. Проспективные контролируемые исследования больных в критическом состоянии подтверждают, что клиренс низкомолекулярных веществ с помощью ПЕД сравним с прерывистым гемодиализом и непрерывной вено-венозной гемофильтрацией, даже когда последняя применяется с высокими скоростями замещения жидкости. Кроме того, сердечно-сосудистая стабильность у пациентов при ПЕД сходна со стабильностью при непрерывных методах заместительной почечной терапии. Режим проведения ежедневного диализа в ночное время имеет дополнительную пользу от того, что не ограничивает доступ персонала ОИТ к пациенту в течение дня, минимизирует взаимодействие заместительной почечной терапии с другими процедурами ОИТ. Таким образом, ПЕД сочетает в себе преимущества как интермиттирующего гемодиализа, так и непрерывных процедур, что делает его практически идеальным методом лечения больных с почечной недостаточностью в условиях реанимационной практики. Хотя проспективные клинические исследования еще не завершены, все доступные в настоящее время данные свидетельствуют, что исходы лечения пациентов на ПЕД не отличаются при прогнозируемой тяжести болезни от результатов лечения с использованием непрерывной заместительной почечной терапии. Вследствие этого многие центры в мире уже применяют эту «гибридную» технику, используя модифицированное стандартное диализное оборудование. ПЕД также предлагает достаточные возможности для взаимодействия между нефрологами и реаниматологами с разделением ответственности. Нефрологический персонал отвечает за назначение, начало и обеспечение лечения, в то время как специалисты ОИТ отвечают за мониторирование, варианты ультрафильтрации, осложнения и окончание процедуры. Такой совместный подход к ведению пациентов является оптимальным для больных в критическом состоянии, при котором используются новые подходы и знания двух специальностей в ОИТ. По нашему мнению, ПЕД станет основным методом заместительной почечной терапии при остром повреждении почек у пациентов в критическом состоянии.</p></abstract><trans-abstract xml:lang="en"><p>Extended daily dialysis (EDD) is becoming increasingly popular method of extracorporal substitutive therapy for patients with acute lesion of kidneys in practice of the department of intensive care (DIC). Long dialysis time (usually 8-18 hours), low flow of dialysate and blood are the key elements of EDD as a method of substitutive renal therapy. Prospective controlled investigations of patients in critical state confirm that clearance of low-molecular substances used in DIC can be compared with interrupted hemodialysis and uninterrupted veno-venous hemofiltration even when the latter was used with high speeds of liquid substitution. In addition, the cardio-vascular stability in patients with EDD was similar with that in uninterrupted methods of substitutive renal therapy. The regimen of performing daily dialysis at night has an additional use because it does not cut down the access of the DIC personnel to the patient during day, minimize the interaction of the substitutive renal therapy with other DIC procedures. Thus EDD has a combination of both intermitting hemodialysis and uninterrupted procedures, that make it a practically ideal method to treat patients with renal failure under conditions of practice of resuscitation. Although, the prospective clinical investigations have not been finished yet, all the available at present data show that outcomes of treatment of the patients on EDD are not different in predicted degree of the disease from the results of treatment using uninterrupted substitutive renal therapy. Hence, many Centers of the world are already using this “hybrid” technique, using modified standard dialysis equipment. EDD also proposes sufficient possibilities for the interaction between nephrologists and resuscitators with divided responsibility. The nephrological personnel are responsible for the prescriptions, beginning and maintenance of the treatment, while specialists of DIC are responsible for monitoring, variants of ultrafiltration, complications and completion of the procedures. Such joint access to the management of the patients is optimal for the patients in critical state, where new accesses and knowledge of two specialties in DIC are used. We think that EDD will be the principal method of substitutive renal therapy in acute lesion f the kidneys in patients in critical state.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>острое повреждение почек (ОПП)</kwd><kwd>непрерывная заместительная почечная терапия (НЗПТ)</kwd><kwd>Отделение интенсивной терапии (ОИТ)</kwd><kwd>прерывистый гемодиализ (ПГД)</kwd><kwd>продлённый ежедневный диализ (ПЕД)</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acute kidney injury (AKI)</kwd><kwd>continuous renal replacement therapy (CRRT)</kwd><kwd>intensive care unit (ICU)</kwd><kwd>intermittend hemodialysis (IHD)</kwd><kwd>extended daily dialysis (EDD)</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kolff WJ. Lasker Clinical Medical Research Award. The artificial kidney and its effect on the development of other artificial organs. Nat Med 2002; 8: 1063-1065</mixed-citation><mixed-citation xml:lang="en">Kolff WJ. Lasker Clinical Medical Research Award. The artificial kidney and its effect on the development of other artificial organs. Nat Med 2002; 8: 1063-1065</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Metnitz PG, Krenn CG, Steltzer H et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002; 30: 2051-2058</mixed-citation><mixed-citation xml:lang="en">Metnitz PG, Krenn CG, Steltzer H et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002; 30: 2051-2058</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818</mixed-citation><mixed-citation xml:lang="en">Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mehta RL, Pascual MT, Soroko S et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 2004; 66: 1613-1621</mixed-citation><mixed-citation xml:lang="en">Mehta RL, Pascual MT, Soroko S et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 2004; 66: 1613-1621</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Schortgen F, Soubrier N, Delclaux C et al. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines. Am J Respir Crit Care Med 2000; 162: 197-202</mixed-citation><mixed-citation xml:lang="en">Schortgen F, Soubrier N, Delclaux C et al. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines. Am J Respir Crit Care Med 2000; 162: 197-202</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 2004; 44: 1000-1007</mixed-citation><mixed-citation xml:lang="en">Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 2004; 44: 1000-1007</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Uehlinger DE, Jakob SM, Ferrari P et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 2005; 20: 1630-1637</mixed-citation><mixed-citation xml:lang="en">Uehlinger DE, Jakob SM, Ferrari P et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 2005; 20: 1630-1637</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ronco C, Bellomo R, Homel P et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26-30</mixed-citation><mixed-citation xml:lang="en">Ronco C, Bellomo R, Homel P et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26-30</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 305-310</mixed-citation><mixed-citation xml:lang="en">Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 305-310</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Berbece AN, Richardson RM. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal. Kidney Int 2006; 70: 963-968</mixed-citation><mixed-citation xml:lang="en">Berbece AN, Richardson RM. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal. Kidney Int 2006; 70: 963-968</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Fiaccadori E, Maggiore U, Rotelli C et al. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Crit Care Med 2004; 32: 2437-2442</mixed-citation><mixed-citation xml:lang="en">Fiaccadori E, Maggiore U, Rotelli C et al. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Crit Care Med 2004; 32: 2437-2442</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kielstein JT, Kretschmer U, Ernst T et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 2004; 43: 342-349</mixed-citation><mixed-citation xml:lang="en">Kielstein JT, Kretschmer U, Ernst T et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 2004; 43: 342-349</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar VA, Craig M, Depner TA, Yeun JY. Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis 2000; 36: 294-300</mixed-citation><mixed-citation xml:lang="en">Kumar VA, Craig M, Depner TA, Yeun JY. Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis 2000; 36: 294-300</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar VA, Yeun JY, Depner TA, Don BR. Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report. Int J Artif Organs 2004; 27: 371-379</mixed-citation><mixed-citation xml:lang="en">Kumar VA, Yeun JY, Depner TA, Don BR. Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report. Int J Artif Organs 2004; 27: 371-379</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lonnemann G, Floege J, Kliem V et al. Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system. Nephrol Dial Transplant 2000; 15: 1189-1193</mixed-citation><mixed-citation xml:lang="en">Lonnemann G, Floege J, Kliem V et al. Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system. Nephrol Dial Transplant 2000; 15: 1189-1193</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Marshall MR, Golper TA, Shaver MJ, Chatoth DK. Hybrid renal replacement modalities for the critically ill. Contrib Nephrol 2001; 252-257</mixed-citation><mixed-citation xml:lang="en">Marshall MR, Golper TA, Shaver MJ, Chatoth DK. Hybrid renal replacement modalities for the critically ill. Contrib Nephrol 2001; 252-257</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Marshall MR, Golper TA, Shaver MJ et al. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. Am J Kidney Dis 2002; 39: 556-570</mixed-citation><mixed-citation xml:lang="en">Marshall MR, Golper TA, Shaver MJ et al. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. Am J Kidney Dis 2002; 39: 556-570</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Naka T, Baldwin I, Bellomo R et al. Prolonged daily intermittent renal replacement therapy in ICU patients by ICU nurses and ICU physicians. Int J Artif Organs 2004; 27: 380-387</mixed-citation><mixed-citation xml:lang="en">Naka T, Baldwin I, Bellomo R et al. Prolonged daily intermittent renal replacement therapy in ICU patients by ICU nurses and ICU physicians. Int J Artif Organs 2004; 27: 380-387</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ratanarat R, Brendolan A, Volker G et al. Phosphate kinetics during different dialysis modalities. Blood Purif 2005; 23: 83-90</mixed-citation><mixed-citation xml:lang="en">Ratanarat R, Brendolan A, Volker G et al. Phosphate kinetics during different dialysis modalities. Blood Purif 2005; 23: 83-90</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Schlaeper C, Amerling R, Manns M, Levin NW. High clearance continuous renal replacement therapy with a modified dialysis machine. Kidney Int Suppl 1999; 72: S20-S23</mixed-citation><mixed-citation xml:lang="en">Schlaeper C, Amerling R, Manns M, Levin NW. High clearance continuous renal replacement therapy with a modified dialysis machine. Kidney Int Suppl 1999; 72: S20-S23</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Marshall MR, Golper TA, Shaver MJ et al. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 2001; 60: 777-785</mixed-citation><mixed-citation xml:lang="en">Marshall MR, Golper TA, Shaver MJ et al. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 2001; 60: 777-785</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Hall FS, Shaver MJ, Marshall MR. Daily 12-hour sustained low-efficiency hemodialysis (SLED): A nursing perspective. Blood Purif 1999; 17: 36 A</mixed-citation><mixed-citation xml:lang="en">Hall FS, Shaver MJ, Marshall MR. Daily 12-hour sustained low-efficiency hemodialysis (SLED): A nursing perspective. Blood Purif 1999; 17: 36 A</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Liao Z, Zhang W, Hardy PA et al. Kinetic comparison of different acute dialysis therapies. Artif Organs 2003; 27: 802-807</mixed-citation><mixed-citation xml:lang="en">Liao Z, Zhang W, Hardy PA et al. Kinetic comparison of different acute dialysis therapies. Artif Organs 2003; 27: 802-807</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Eloot S, Van Biesen W, Dhondt A et al. Impact of hemodialysis duration on the removal of uremic retention solutes.Kidney Int 2007</mixed-citation><mixed-citation xml:lang="en">Eloot S, Van Biesen W, Dhondt A et al. Impact of hemodialysis duration on the removal of uremic retention solutes.Kidney Int 2007</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Palevsky PM, O’Connor T, Zhang JH et al. Design of the VA/NIH Acute Renal Failure Trial Network (ATN) Study: intensive versus conventional renal support in acute renal failure. Clin Trials 2005; 2: 423-435</mixed-citation><mixed-citation xml:lang="en">Palevsky PM, O’Connor T, Zhang JH et al. Design of the VA/NIH Acute Renal Failure Trial Network (ATN) Study: intensive versus conventional renal support in acute renal failure. Clin Trials 2005; 2: 423-435</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Davenport A, Bouman C, Kirpalani A et al. Delivery of renal replacement therapy in acute kidney injury: What are the key issues? Clin J Am Soc Nephrol 2008</mixed-citation><mixed-citation xml:lang="en">Davenport A, Bouman C, Kirpalani A et al. Delivery of renal replacement therapy in acute kidney injury: What are the key issues? Clin J Am Soc Nephrol 2008</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Morgera S, Scholle C, Melzer C et al. A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure. Nephron Clin Pract 2004; 98: c35-c40</mixed-citation><mixed-citation xml:lang="en">Morgera S, Scholle C, Melzer C et al. A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure. Nephron Clin Pract 2004; 98: c35-c40</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Marshall MR, Ma T, Galler D et al. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant 2004; 19: 877-884</mixed-citation><mixed-citation xml:lang="en">Marshall MR, Ma T, Galler D et al. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant 2004; 19: 877-884</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Barenbrock M, Hausberg M, Matzkies F et al. Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients.Kidney Int 2000; 58: 1751-1757</mixed-citation><mixed-citation xml:lang="en">Barenbrock M, Hausberg M, Matzkies F et al. Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients.Kidney Int 2000; 58: 1751-1757</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">van der Sande FM, Kooman JP, Konings CJ, Leunissen KM. Thermal effects and blood pressure response during postdilution hemodiafiltration and hemodialysis: the effect of amount of replacement fluid and dialysate temperature. J Am Soc Nephrol 2001; 12: 1916-1920</mixed-citation><mixed-citation xml:lang="en">van der Sande FM, Kooman JP, Konings CJ, Leunissen KM. Thermal effects and blood pressure response during postdilution hemodiafiltration and hemodialysis: the effect of amount of replacement fluid and dialysate temperature. J Am Soc Nephrol 2001; 12: 1916-1920</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kanagasundaram NS, Larive AB, Paganini EP. A preliminary survey of bacterial contamination of the dialysate circuit in continuous veno-venous hemodialysis. Clin Nephrol 2003; 59: 47-55</mixed-citation><mixed-citation xml:lang="en">Kanagasundaram NS, Larive AB, Paganini EP. A preliminary survey of bacterial contamination of the dialysate circuit in continuous veno-venous hemodialysis. Clin Nephrol 2003; 59: 47-55</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Burkhardt O, Joukhadar C, Traunmuller F et al. Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis. J Antimicrob Chemother 2008; 61: 224-225</mixed-citation><mixed-citation xml:lang="en">Burkhardt O, Joukhadar C, Traunmuller F et al. Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis. J Antimicrob Chemother 2008; 61: 224-225</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Czock D, Husig-Linde C, Langhoff A et al. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clin J Am Soc Nephrol 2006; 1: 1263-1268</mixed-citation><mixed-citation xml:lang="en">Czock D, Husig-Linde C, Langhoff A et al. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clin J Am Soc Nephrol 2006; 1: 1263-1268</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kielstein JT, Stadler M, Czock D et al. Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure. Eur J Haematol 2005; 74: 533-534</mixed-citation><mixed-citation xml:lang="en">Kielstein JT, Stadler M, Czock D et al. Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure. Eur J Haematol 2005; 74: 533-534</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kielstein JT, Czock D, Schopke T et al. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis. Crit Care Med 2006; 34: 51-56</mixed-citation><mixed-citation xml:lang="en">Kielstein JT, Czock D, Schopke T et al. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis. Crit Care Med 2006; 34: 51-56</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Kielstein JT, Schwarz A, Arnavaz A et al. High-flux hemodialysis—an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication. Clin Nephrol 2002; 57: 484-486</mixed-citation><mixed-citation xml:lang="en">Kielstein JT, Schwarz A, Arnavaz A et al. High-flux hemodialysis—an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication. Clin Nephrol 2002; 57: 484-486</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Kielstein JT, Woywodt A, Schumann G et al. Efficiency of high-flux hemodialysis in the treatment of valproic acid intoxication. J Toxicol Clin Toxicol 2003; 41: 873-876</mixed-citation><mixed-citation xml:lang="en">Kielstein JT, Woywodt A, Schumann G et al. Efficiency of high-flux hemodialysis in the treatment of valproic acid intoxication. J Toxicol Clin Toxicol 2003; 41: 873-876</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Kielstein JT, Linnenweber S, Schoepke T, Fliser D. One for all–a multi-use dialysis system for effective treatment of severe thallium intoxication. Kidney Blood Press Res 2004; 27: 197-199</mixed-citation><mixed-citation xml:lang="en">Kielstein JT, Linnenweber S, Schoepke T, Fliser D. One for all–a multi-use dialysis system for effective treatment of severe thallium intoxication. Kidney Blood Press Res 2004; 27: 197-199</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Dhondt A, Verstraete A, Vandewoude K et al. Efficiency of the Genius batch hemodialysis system with low serum solute concentrations: the case of lithium intoxication therapy. Am J Kidney Dis 2005; 46: e95-e99</mixed-citation><mixed-citation xml:lang="en">Dhondt A, Verstraete A, Vandewoude K et al. Efficiency of the Genius batch hemodialysis system with low serum solute concentrations: the case of lithium intoxication therapy. Am J Kidney Dis 2005; 46: e95-e99</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Alam M, Marshall M, Shaver M, Chatoth D. Cost comparison between sustained low efficiency hemodialysis (SLED) and continuous venovenous hemofiltration (CVVH) for ICU patients with ARF. Am J Kidney Dis 2000; 35: A9</mixed-citation><mixed-citation xml:lang="en">Alam M, Marshall M, Shaver M, Chatoth D. Cost comparison between sustained low efficiency hemodialysis (SLED) and continuous venovenous hemofiltration (CVVH) for ICU patients with ARF. Am J Kidney Dis 2000; 35: A9</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Ma T, Walker JA, Eggleton K, Marshall M. Cost comparison between sustained low efficiency daily dialysis / diafiltration (SLEDD) and continuous renal replacement therapy for ICU patients with ARF. Nephrology (Carlton)7, A54. 2002. Abstract</mixed-citation><mixed-citation xml:lang="en">Ma T, Walker JA, Eggleton K, Marshall M. Cost comparison between sustained low efficiency daily dialysis / diafiltration (SLEDD) and continuous renal replacement therapy for ICU patients with ARF. Nephrology (Carlton)7, A54. 2002. Abstract</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Golper TA. Hybrid renal replacement therapies for critically ill patients. Contrib Nephrol 2004; 144: 278-283</mixed-citation><mixed-citation xml:lang="en">Golper TA. Hybrid renal replacement therapies for critically ill patients. Contrib Nephrol 2004; 144: 278-283</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lameire N, Van Biesen W, Vanholder R. Dialysing the patient with acute renal failure in the ICU: the emperor’s clothes? Nephrol Dial Transplant 1999; 14: 2570-2573</mixed-citation><mixed-citation xml:lang="en">Lameire N, Van Biesen W, Vanholder R. Dialysing the patient with acute renal failure in the ICU: the emperor’s clothes? Nephrol Dial Transplant 1999; 14: 2570-2573</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Mehta RL, McDonald B, Gabbai F et al. Nephrology consultation in acute renal failure: does timing matter? Am J Med 2002; 113: 456-461</mixed-citation><mixed-citation xml:lang="en">Mehta RL, McDonald B, Gabbai F et al. Nephrology consultation in acute renal failure: does timing matter? Am J Med 2002; 113: 456-461</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
